These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23796225)

  • 21. Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.
    Goyal S; Grover S; Dhanjal JK; Tyagi C; Goyal M; Grover A
    J Mol Graph Model; 2014 Jun; 51():64-72. PubMed ID: 24858256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical, molecular-orbital and electronic properties of acephate and methamidophos.
    Singh AK; White T; Spassova D; Jiang Y
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jan; 119(1):107-17. PubMed ID: 9568380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative structure-activity relationships for organophosphates binding to acetylcholinesterase.
    Ruark CD; Hack CE; Robinson PJ; Anderson PE; Gearhart JM
    Arch Toxicol; 2013 Feb; 87(2):281-9. PubMed ID: 22990135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).
    Araújo JQ; de Brito MA; Hoelz LV; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
    Eur J Med Chem; 2011 Jan; 46(1):39-51. PubMed ID: 21074294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
    Roy KK; Dixit A; Saxena AK
    J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
    Roy PP; Roy K
    J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo QSAR models for predicting organophosphate inhibition of acetycholinesterase.
    Veselinović JB; Nikolić GM; Trutić NV; Živković JV; Veselinović AM
    SAR QSAR Environ Res; 2015 Jun; 26(6):449-60. PubMed ID: 26043064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR modeling and molecular interaction analysis of natural compounds as potent neuraminidase inhibitors.
    Sun J; Mei H
    Mol Biosyst; 2016 Apr; 12(5):1667-75. PubMed ID: 27008437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
    Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
    J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
    J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies.
    Contreras-Romo MC; Martínez-Archundia M; Deeb O; Slusarz MJ; Ramírez-Salinas G; Garduño-Juárez R; Quintanar-Stephano A; Ramírez-Galicia G; Correa-Basurto J
    Chem Biol Drug Des; 2014 Feb; 83(2):207-23. PubMed ID: 24010681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, biological evaluation, and molecular modeling of coumarin-piperazine derivatives as acetylcholinesterase inhibitors.
    Modh RP; Kumar SP; Jasrai YT; Chikhalia KH
    Arch Pharm (Weinheim); 2013 Nov; 346(11):793-804. PubMed ID: 24591157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated approach with new strategies for QSAR models and lead optimization.
    Hsu HH; Hsu YC; Chang LJ; Yang JM
    BMC Genomics; 2017 Mar; 18(Suppl 2):104. PubMed ID: 28361681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
    Jung M; Tak J; Lee Y; Jung Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1082-90. PubMed ID: 17158047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR analyses of organophosphates for insecticidal activity and its in-silico validation using molecular docking study.
    Niraj RR; Saini V; Kumar A
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):886-94. PubMed ID: 26492451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of acetylcholinesterase from elm left beetle, Xanthogaleruca luteola and QSAR of temephos derivatives against its activity.
    Sharifi M; Ghadamyari M; Gholivand K; Valmoozi AAE; Sajedi RH
    Pestic Biochem Physiol; 2017 Mar; 136():12-22. PubMed ID: 28187825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular engineering and activity improvement of acetylcholinesterase inhibitors: Insights from 3D-QSAR, docking, and molecular dynamics simulation studies.
    Gao W; Ma X; Yang H; Luan Y; Ai H
    J Mol Graph Model; 2022 Nov; 116():108239. PubMed ID: 35696774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR analysis of a new type of acetylcholinesterase inhibitors.
    Liu A; Guang H; Zhu L; Du G; Lee SM; Wang Y
    Sci China C Life Sci; 2007 Dec; 50(6):726-30. PubMed ID: 17914643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.